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In ventricular muscle from 30- to 60-day-old Bio 14.6 cardiomyopathic hamsters, dystrophin-associated glycoproteins of 43, 50 and 150 kDa are 
markedly reduced in abundance. In particular, the 50-kDa glycoprotein is totally deficient in the sarcolemma of myopathic ventricular myocytes 
as revealed by immunofluorescence microscopy. The dystrophin-glycoprotein complex formation is defective in the cardiomyopathic hamster heart, 
because dystrophin and the glycoproteins behave independently when digitonin-solubilized ventricular homogenates are fractionated on wheat germ 
agglutinin beads or anti-dystrophin immunoafBnity beads. 
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1. INTRODUCTION 
The cardiomyopathic Syrian hamster develops a ge- 
netically determined cardiomyopathy, characterized by 
spontaneous necrosis of cardiomyocytes occurring at 
relatively early ages (30 to 50 days after birth), which 
leads to hypertrophy and ultimate failure of the heart 
and to death at about 300 days of age [l]. This animal 
model can be a good, experimental tool for the study of 
the disease mechanism of human hereditary cardiomy- 
opathy, although it also develops cell necrosis in skeletal 
muscle. Previous studies suggest that cell necrosis is 
caused by calcium overloading of myopathic cardiomy- 
ocytes which may arise from abnormal calcium han- 
dling by these cells [2]. However, the primary defect 
causing such cell necrosis has not been identified. 
amination revealed that dystrophin binds to the 
glycoprotein complex at the cysteine-rich domain and 
the first half of the C-terminal domain [9]. The dystro- 
phin-associated glycoprotein complex consists of at 
least three integral membrane glycoproteins of 35, 43 
and 50 kDa, which were designated A4, A3 and A2, 
respectively [lo], and an extracellular, laminin-binding 
glycoprotein of 156 kDa [lO-121. Thus glycoproteins 
link the dystrophin skeleton to the sarcolemma nd to 
the extracellular matrix, structurally stabilizing the sar- 
colemma. 
A similar progressive muscular dystrophy is known 
to occur in skeletal muscle of patients with Duchenne 
muscular dystrophy (DMD), which is caused by the 
lack of dystrophin, the high molecular weight protein 
product of the DMD gene [3,4]. In striated muscle cells, 
dystrophin is localized at the inner surface of the sar- 
colemma, presumably forming a sub-membrane cy- 
toskeletal network [4-61. Dystrophin binds to actin at 
its N-terminal side and a complex of membrane 
glycoproteins at its C-terminal side [7-91. Detailed ex- 
Recently, we have shown that dystrophin is 50% less 
abundant in cardiomyopathic hamster ventricle com- 
pared with normal control and that despite its low 
abundance, extraction of dystrophin from the ventricu- 
lar muscle into the microsomal fraction is increased 
fourfold in cardiomyopathic hamster [131. This suggests 
an altered membrane-dystrophin association in the car- 
diomyopathic hamster, which could result from a defect 
in the sarcolemmal glycoproteins that dystrophin an- 
chors. Here we report markedly decreased abundance 
of the 43-, 50- and 150-kDa glycoproteins, and disrup- 
tion of the integrity of the dystrophin-glycoprotein com- 
plex in myopathic hamster cardiomyocytes. 
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2. MATERIALS AND METHODS 
2.1. Animals 
Thirty- to sixty-day-old Syrian hamsters of the Bio 14.6 strain and 
age-matched control Golden hamsters were used as experimental ni- 
mals [13,15]. 
Abbreviations: DMD, Duchenne muscular dystrophy; TCA, trichlo- 
roacetic acid; WGA, wheat germ agglutinin; LBP, laminin binding 
protein; NAG, N-acetyl-o-glucosamine. 
2.2. Preparation of TCA homogenates 
A hamster ventricle (0.18 g) was cut into pieces in 10% TCA (1 ml) 
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and then homogenized three times for 30 s with an ultra high speed 
Physcotron NS-60 homogenizer (NITI-ON Instruments CO.) at 
25,000 rpm. After centrifugation at 5,500 x g (max) for 20 min, the 
pellet was completely dissolved in 1 ml of 0.1 M NaHCO,, 2% SDS 
and 1 mM EDTA by ultrasonic treatment. 
2.3. Antibodies 
Monoclonal mouse antibodies against the rod domain (NCL- 
DYSl) and the COOH-terminal region (NCL-DYS2) of human 
dystrophin were purchased from Novocastle Laboratories. Polyclonal 
rabbit antiserum to laminin purified from rat yolk sac tumor L2 was 
obtained from Gibco Laboratories. Polyclonal antibodies against A3a 
(PA3a) and A2 (PA2), which were the 43- and SO-kDa dystrophin- 
associated glycoproteins from skeletal muscle [lo], were produced in 
rabbits using synthetic polypeptides [14]. All these antibodies recog- 
nized single proteins of the expected molecular weight for the target 
proteins in the dystrophin-glycoprotein complex purified from rabbit 
skeletal muscle (data not shown) or in the hamster ventricular homo- 
genates (Fig. 1). Preparation of a polyclonal rabbit antibody against 
cl-subunit of Na+,K’-ATPase was described in [16]. 
2.4. Immunoblot analysis and detection of Iaminin binding proteins 
TCA homogenates (60 pg) or samples (20 ~1) eluted from WGA- 
Sepharose or dystrophin immunoaffinity beads were electrophoresed 
on 420% gradient or 5 or 7.5% SDS-polyacrylamide gels according 
to Laemmli [17]. For immunoblotting, the proteins in the gels were 
transferred to Immobilon membranes (Millipore) with an efficiency 
higher than 83% even for dystrophin. Immobilon membranes were 
treated with a specific antibody and a peroxidase-conjugated second- 
ary antibody as described in [15]. The protein recognized by each 
specific antibody was quantified by using Amersham ECL im- 
munoblotting detection system also as described [15,16]. For detection 
of laminin binding proteins, Immobilon transfers were treated with 
purified rat laminin (1 fig) (TELIOS Pharmaceuticals) for 30 min at 
37°C washed free of unbound laminin and then incubated with poly- 
clonal rat anti-laminin antibody for 30 min at 37°C. The protein- 
bound laminin recognized by anti-laminin antibody was quantified as 
described above. Control experiments were done without the laminin 
overlay. 
2.5. Isolation of dystrophin and its associatedproteins using dystrophin 
immunoaffinity beads or WGA-Sepharose beads 
Hamster ventricle (0.2 g) was homogenized for 30 s three times with 
Physcotron NS-60 at 25,000 rpm in buffer A (1 ml) (1% digitonin, 0.5 
M NaCl, 50 mM Tris-HCl (pH 7.4), 0.25 mM phenylmethanesulfonyl 
fluoride, 1.5 mM benzamidine, 2.5 &ml leupeptin, 2.5 pglml apro- 
tinin, and 2.5 &ml pepstatin A). After centrifugation at 540,000 x g 
(max), the supematant (20 mg protein) was incubated overnight at 
4°C either with anti-mouse IgG Sepharose beads (50 ~1) (Sigma) 
carrying anti-dystrophin antibody (NCL-DYS2) or with WGA- 
Sepharose 6 MB beads (100 ~1) (Pharmacia-LKB). The beads then 
were washed extensively with buffer A and eluted with SDS sample 
buffer (100 ~1) containing 4% SDS, 200 mM DTT and 20% glycerol 
(for immunoaffinity beads) or buffer A (1 ml) containing 0.6 M NAG 
(for WGA-Sepharose beads). The sample eluted from WGA-Sepha- 
rose was precipitated by the addition of 100% TCA (100 ~1) and the 
resultant precipitate was dissolved with SDS sample buffer (50 ~1). 
2.6. ImmunoJluorescence microscopy 
Frozen sections (6 pm) of hamster ventricular muscle were incu- 
bated for 30 min in PBS (0.9% NaCl, 50 mM sodium phosphate, pH 
7.5) containing 5% defatted dry milk (PBS/milk) and stained for 1 h 
with a monoclonal antibody against dystrophin @JCL-DYSl) or a 
polyclonal antibody against the 43-kDa (PA3a) or 50-kDa (PA2) 
dystrophin-associated glycoprotein. Samples were washed, blocked 
again for 15 min in PBS/milk, and then treated with FITCconjugated 
anti-mouse IgG or FITC-conjugated anti-rabbit IgG (Organon 
Teknika N.V.-Cappel products). Visualization of samples was per- 
formed as described previously [13]. 
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Fig. 1. Immunoblot analysis of ventricular homogenates from control 
and myopathic hamster. TCA homogenates (60 pug) were subjected to 
SDS polyacrylamide gel electrophoresis. For CBB, gels were stained 
with Coomassie brilliant blue. For other gels, proteins were blotted 
to Immobilon membranes and then immunostained as described in 
section 2 with antibodies against he indicated proteins (lane 1, sam- 
ples from normal hamster; lane 2, samples from myopathic hamsters). 
Arrows show the positions of laminin and the laminin binding protein 
(LBP). Molecular mass standards are shown on the left. 
3. RESULTS 
Fig. 1 shows immunoblots of ventricular homoge- 
nates from normal and cardiomyopathic hamsters with 
anti-dystrophin antibody, PA3a, PA2 and anti-laminin 
antibody. The figure also shows relative abundance of 
a 150-kDa laminin-binding protein (LBP) in normal 
and myopathic ventricular homogenates, which was vis- 
ualized by laminin overlay followed by staining with an 
anti-laminin antibody (see section 2). This 150-kDa 
LBP probably is a cardiac form of the 156-kDa dystro- 
phin- associated glycoprotein which was shown to be a 
major LBP in crude skeletal muscle membranes [ 121 (see 
section 4). Immunoblot analysis revealed that dystro- 
phin, the 43- and 50-kDa glycoproteins, and the 150- 
kDa LBP were markedly reducediin myopathic ventri- 
cle compared with normal control. The reductions were 
42 f 13% (n = 4) for dystrophin, 85 f 13% (n = 5) for 
the 50-kDa glycoprotein, 61 + 8% (n = 4) for the 43- 
kDa glycoprotein, and 92 f 10% (n = 4) for the 150- 
kDa LBP, as estimated by quantitative immunoblot 
assay. In contrast, there was no difference in the laminin 
content between normal and cardiomyopathic ham- 
sters. 
Greater reductions of the 43- and 50-kDa glycopro- 
teins and the 150-kDa LBP relative to dystrophin in 
myopathic ventricular muscle prompted us to investi- 
gate the association status of these proteins with dystro- 
phin. We solubilized dystrophin and its associated pro- 
teins from ventricular homogenates by treating the lat- 
ter directly with 0.5 M NaCl and 1% digitonin (see 
section 2). About 50 and 67% of total dystrophin were 
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Fig. 2. Isolation of dystrophin and its associated proteins using WGA- 
Sepharose beads. Digitonin-solubilized ventricular homogenates from 
normal or myopathic hamsters were loaded onto WGA-Sepharose 
beads. Proteins were eluted with 0.6 M NAG and subsequently precip- 
itated by the addition of TCA as described in section 2. The TCA 
precipitate was dissolved with SDS sample buffer and analyzed by 
SDS-PAGE and immunoblotting (lane 1, samples from normal ham- 
ster; lane 2, samples from myopathic hamsters). Immobilon transfers 
were stained with antibodies to the indicated proteins as in Fig. 1. 
extracted into soluble fractions from normal and my- 
opathic ventricular homogenates, respectively. We then 
incubated the solubilized material with WGA-Sepha- 
rose beads. Immunoblot analysis revealed that dystro- 
phin, the 43- and 50-kDa glycoproteins and the 150- 
kDa LBP from normal hamster ventricle were retained 
on WGA Sepharose, from which they were eluted with 
NAG (Fig. 2, lane 1). On the other hand, dystrophin, 
the 50-kDa glycoprotein, and the 150-kDa LBP from 
myopathic hamster ventricle were not detectable in the 
NAG-eluted fraction from WGA-Sepharose under the 
conditions of Fig. 2 (Fig. 2, lane 2). When the amount 
of the solubilized material loaded onto WGA-Sepha- 
rose was increased threefold, the presence of the 150- 
kDa LBP but not the 50-kDa glycoprotein became de- 
tectable in the NAG-eluted fraction (data not shown). 
In these NAG-eluted fractions from normal and my- 
opathic hamsters, Na’,K’-ATPase was found to be 
present at equal levels, as estimated by immunoblotting 
with an antibody against the a-subunit of this enzyme 
(data not shown). The Na’,K’-ATPase was retained by 
WGA-Sepharose probably via its j? subunit. Thus we 
conclude that dystrophin from myopathic hamster is 
not retained on WGA-Sepharose, as opposed to the 
43-kDa glycoprotein and the 150-kDa LBP from the 
same hamster. The same results were obtained with 
succinylated WGA-Sepharose. 
Association of dystrophin with its associated proteins 
was also analyzed by immunoprecipitation of dystro- 
phin (Fig. 3). Dystrophin immunoaffinity beads were 
incubated with the digitonin-solubilized material from 
normal or myopathic hamster ventricular homogenates. 
After extensive washing, proteins were eluted from the 
immunoaffinity beads with SDS buffer and analyzed by 
SDS-PAGE and immunoblotting. Dystrophin immu- 
noaffinity beads immunoprecipitated the 43- and 50- 
kDa glycoproteins and the 150-kDa LBP together with 
dystrophin from normal ventricular homogenates (Fig. 
3, lane 1). In contrast, these dystrophin-associated pro- 
teins were not immunoprecipitated from myopathic 
ventricular homogenates with the same immunoaffinity 
beads (Fig. 3, lane 2). 
We investigated the distribution of dystrophin and its 
associated proteins in ventricular muscles from normal 
and myopathic hamsters by indirect immunofluores- 
cence microscopy (Fig. 4). We showed previously that 
anti-dystrophin antibody uniformly and similarly 
stained the peripheral sarcolemma and T tubules of 
both normal and myopathic hamster cardiomyocytes 
[13]. We confirmed these findings in cross (Fig. 4a and 
b) and longitudinal sections (data not shown) of ventric- 
ular muscles from normal and myopathic hamsters. We 
found that in normal hamster cardiomyocytes, distribu- 
tions of the 43- and 50-kDa glycoproteins as stained 
with PA3a and PA2, respectively, were essentially the 
same as that of dystrophin (Fig. 4a,c,e). A recent paper 
by Klietsch et al. presented similar results by using pap- 
illary muscles from several animals . [18]. The im- 
munostaining patterns of normal and myopathic ham- 
ster cardiomyocytes with PA3a were also indistinguish- 
able (Fig. 4e and f). Intriguingly, however, PA2 did not 
label the sarcolemma of myopathic hamster cardiomy- 
ocytes (Fig. 4d). Thus the 50-kDa glycoprotein is defi- 
cient in the myopathic sarcolemma. We observed weak 
staining of the interior of these cells with PA2 (Fig. 4d). 
However, such staining did not differ significantly from 
the background staining obtained with preimmune 
serum (data not shown). Lack of staining of the 50-kDa 
glycoprotein in the sarcolemma was observed in ventric- 
ular myocytes from myopathic hamsters ranging from . 
30 to 300 days of age (data not shown). 
4. DISCUSSION 
In this study, we investigated the association of 
dystrophin with proteins of 43, 50 and 150 kDa in car- 
diomyopathic hamster heart. These proteins are most 
likely cardiac equivalents to A3a (the 43-kDa glycopro- 
tein), A2 (the 50-kDa glycoprotein) and the 156-kDa 
glycoprotein of the dystrophin-glycoprotein complex in 
skeletal muscle [ 1 &12] for the following reasons; (1) the 
cardiac 43- and 50-kDa proteins were recognized re- 
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Fig. 3. Isolation of dystrophin and its associated proteins using anti- 
dystrophin immunoaffinity beads. Digitonin-solubilized ventricular 
homogenates from normal and myopathic hamsters were loaded onto 
anti-dystrophin immunoaffinity beads and then proteins were eluted 
with SDS sample buffer as described in section 2. Eluted proteins were 
analyzed by SDS-PAGE and immunoblotting (lane 1, samples from 
normal hamster; lane 2, samples from myopathic hamster). Immo- 
bilon transfers were stained with antibodies to the indicated proteins 
as in Fig. 1. 
spectively by antibodies PA3a and PA2 raised against 
the 43- and 50-kDa components of the skeletal muscle 
dystrophin-glycoprotein complex and, like dystrophin, 
localized to the peripheral sarcolemma nd T tubules in 
normal cardiomyocytes (Fig. 4); (2) they were retained 
on WGA-Sepharose and eluted with NAG and immu- 
noadsorbed to anti-dystrophin immunoafhnity beads, 
when digitonin-solubilized ventricular homogenates 
from normal hamster were treated with these beads 
(Figs. 2 and 3); (3) the cardiac 150-kDa and skeletal 
156-kDa LBPs were the only laminin-binding proteins 
in the dystrophin-glycoprotein complexes from cardiac 
and skeletal muscles (Fig. 3 and [12]). 
Previously we reported that dystrophin is decreased 
to 50% in myopathic ventricular homogenates and that 
despite such low abundance, extraction of dystrophin 
into the microsomal fraction was fourfold greater from 
myopathic hamster ventricle as compared to normal 
control [ 131. The latter finding suggests that dystrophin 
may be linked to the sarcolemma much less tightly in 
the myopathic cardiomyocytes. This study showed that 
dystrophin from myopathic hamster was not retained 
on WGA-Sepharose (Fig. 2) and that anti-dystrophin 
immunoaffinity beads immunoprecipitated none of the 
above glycoproteins from myopathic hamster (Fig. 3). 
The results clearly indicate that integrity of the dystro- 
phin-glycoprotein complex in the sarcolemma is dis- 
rupted in myopathic cardiomyocytes. 
Such disruption could be caused by defect(s) in 
dystrophin or in the dystrophin-associated glycopro- 
teins. An intriguing finding was that by immunostaining 
with PA2, the 50-kDa glycoprotein was totally deficient 
in the myopathic sarcolemma (Fig. 4d). We observed 
weak positive staining with PA2 in the interior of my- 
opathic cardiomyocytes (Fig. 4d). However, such stain- 
ing was not distinguishable from the background stain- 
ing obtained with pre-immune serum (see section 3). We 
suspect hat a small amount of the 50-kDa glycoprotein 
is present in the interior of myopathic cardiomyocytes, 
because a small amount of the PAZreactive 50-kDa 
protein was detected by immunoblot analysis (see sec- 
Fig. 4. Immunohistochemlcal localization of dystrophin, the 43- and 
50-kDa glycoproteins in ventricular muscles of normal and myopathic 
hamsters. Frozen cross sections of normal (a,c,e) or myopathic (b,d,f) 
ventricular muscle were labeled by indirect immunofluorescence as
described in section 2. Sections were incubated with anti-dystrophin 
antibody (a,b), PA2 (anti-50 kDa glycoprotein) (c,d) and PA3a (anti- 
43 kDa glycoprotein) (e,f,l. Bar in f, 20 pm. 
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tion 3) and because this protein, like dystrophin, exhib- 
ited a significant increase in its abundance in the micro- 
somal fraction prepared from myopathic ventricle 
(Iwata et al., unpublished observation). In contrast to 
the 50-kDa glycoprotein, the 43-kDa glycoprotein was 
present in myopathic ventricular homogenates at about 
40% of the normal level (see Fig. 1 and section 3) and 
its immunostaining pattern in the myopathic cardiomy- 
ocytes was not different from that for the normal con- 
trol (Fig. 4e and f). 
We found that the 150-kDa LBP was also decreased 
to 10% of the control level in the myopathic ventricle, 
as estimated by the measurement of binding of laminin 
to this protein (see Fig. 1 and section 3). The decrease 
in laminin binding could result from decreased abun- 
dance of the 150-kDa LBP and/or reduced ability of this 
protein to bind laminin. We tentatively interpret the 
decreased laminin binding as a reflection of the de- 
creased abundance of the 150-kDa LBP. On the other 
hand, the laminin content in normal and myopathic 
ventricles was not different (Fig. 1). Immunofluores- 
cence analysis with an anti-laminin antibody revealed 
that laminin localizes to the peripheral sarcolemma nd 
T tubules similarly in normal and myopathic cardiomy- 
ocytes (Iwata, Y. et al. unpublished observation). 
The Bio 14.6 cardiomyopathic hamster is known to 
develop cell necrosis also in skeletal muscle [l]. Our 
immunofluorescence analysis revealed that the 50-kDa 
glycoprotein was also absent in the skeletal muscle sar- 
colemma from the myopathic hamster (Iwata, Y. et al., 
unpublished observation). Thus absence of A2 (the 50- 
kDa glycoprotein) in the sarcolemma may well be re- 
sponsible for disruption of the integrity of the dystro- 
phin-glycoprotein complex in myopathic cardiomy- 
ocytes and myopathic skeletal muscle cells. Such disrup- 
tion could secondarily cause reduction of dystrophin 
and some other components of the dystrophin complex 
observed here. Indeed, in skeletal muscle from DMD 
patients and mdx mice, specific deficiency of dystrophin 
was shown to be associated with much reduced abun- 
dance of all the dystrophin-associated proteins [12,19]. 
The possible etiological importance of A2 (the 50-kDa 
glycoprotein) deficiency in muscle dystrophy has been 
suggested by a recent report that it is specifically defi- 
cient in the skeletal muscle sarcolemma from patients 
suffering from severe childhood autosomal recessive 
muscular dystrophy [20], which is a DMD-like progres- 
sive muscular dystrophy. Thus muscle dystrophies 
found in these patients and cardiomyopathic hamsters 
may share a similar mechanism of pathogenesis. 
It should be pointed out that the decreased levels of 
dystrophin and its associated glycoproteins observed in 
this study are not the result of muscle cell necrosis in the 
myopathic hamster ventricle. We reported previously 
that six integral membrane proteins, i.e. the al subunit 
of L-type calcium channels, Na+,K+- ATPase, Na’-H’ 
antiporter, the ryanodine receptor, and sarcoplasmic 
reticulum Ca*‘-ATPase, did not show any difference in 
their abundance between normal and myopathic ven- 
tricular homogenates [ 161. In addition, we showed equal 
abundance of vinculin, a cytoskeletal protein, in normal 
and myopathic ventricular homogenates [ 131. Previous 
studies of several types of skeletal muscle dystrophy 
including human DMD have suggested that loss of in- 
tegrity of the dystrophin-glycoprotein complex may 
somehow lead to sarcolemmal instability and eventually 
to muscle cell necrosis. Our results reported in this and 
previous [13] studies suggest that  defect in the dystro- 
phin-glycoprotein complex may also play a critical role 
in muscle cell necrosis in the hamster cardiomyopathy. 
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